Strong Biopharma Appetite Aids Solid Korean IPO Debuts
This article was originally published in PharmAsia News
Executive Summary
Shares of Green Cross LabCell and ST Pharm jumped on their debut following their successful initial public offerings earlier this month. Numerous South Korean biotechs are seeking IPOs this year amid the government's ongoing drive to nurture the biopharma sector and the stock exchange's efforts to ease listing regulations to help fund raising by promising small firms including bioventures.